FIELD: oncology.
SUBSTANCE: 0.01-0.02 ml of blood serum is placed onto object-plate, dried for 72-96 h under cover glass at room temperature and relative humidity 50-60%, after which sample is examined microscopically in polarized light. When anisotropic spherulytes with single small multicolored inclusions in central parts thereof are revealed, preclinical phase of malignant growth in body is diagnosed. When anisotropic spherulytes with marked colored inclusions are revealed, early phase of malignant neoplasm is diagnosed.
EFFECT: increased diagnostics accuracy.
4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING THE RISK OF MALIGNANT GROWTH | 2016 |
|
RU2651753C1 |
DIAGNOSTIC TECHNIQUE FOR MALIGNANT GROWTH GENERALISATION | 2013 |
|
RU2517527C1 |
METHOD OF DETERMINING DEGREE OF RISK OF MALIGNANT GROWTH | 2009 |
|
RU2413941C1 |
METHOD FOR DIAGNOSIS OF BODY CELLS HYPERPLASIA | 2002 |
|
RU2234856C2 |
METHOD FOR PREDICTING DEGREE OF ATHEROSCLEROTIC LESION IN BLOOD VESSELS | 2001 |
|
RU2207567C2 |
METHOD FOR DIAGNOSING CATARACT | 2000 |
|
RU2173460C1 |
METHOD FOR PREDICTING STAGES OF DISCIRCULATORY ENCEPHALOPATHY | 2001 |
|
RU2207570C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF RADIOTHERAPY IN PATIENTS WITH MALIGNANT TUMORS | 2016 |
|
RU2651755C1 |
METHOD FOR DIAGNOSING UVEAL MELANOMA | 2021 |
|
RU2777205C1 |
METHOD FOR COMPLEX EVALUATION OF POLYCHEMOTHERAPY EFFICIENCY FOR PATIENTS WITH RECURRENT HODGKIN'S LYMPHOMA | 2016 |
|
RU2623143C1 |
Authors
Dates
2004-08-27—Published
2002-05-14—Filed